Issue link: http://osercommunicationsgroup.uberflip.com/i/709452
C h a i n D r u g s t o r e D a i l y 5 1 S u n d a y, A u g u s t 7 , 2 0 1 6 SUN PHARMA CONTINUES EXPANDING PRODUCT PORTFOLIO The world's largest pharmaceuticals mar- ket is also the biggest market for Sun Pharma. It has been present in the U.S. since 1996, working with the country's healthcare system with a focus on gener- ics, branded generics and over-the-count- er (OTC) products. It is a valued supplier to the largest wholesalers, distributors, warehousing and non-warehousing chain drugstores and managed care providers. Being a vertically integrated company with a global presence, Sun Pharma has the flexibility to develop and manufac- ture products in the U.S. as well as at other locations across the world. Its U.S. headquarters are in Cranbury, New Jersey and it has distribution and cus- tomer service teams at multiple locations across the country. Sun Pharma is present in the U.S. through its own legal entities as well as its subsidiary, Taro Pharmaceuticals. Sun Pharma has made several acquisitions in the U.S., including Caraco, DUSA Pharmaceuticals and Pharmalucence. Currently, it is a market leader in the generic dermatology sector, with a broad product portfolio for the treatment of actinic keratosis, fungal infections and acne. It has strong capabilities in devel- oping complex products and has a robust pipeline of ANDAs, including high value First-to-File (FTF) opportunities. Sun Pharma's latest acquisition of a majority interest in Ranbaxy Laboratories Limited (Ranbaxy) and its Ohm Laboratories facilities in the New Jersey makes it the largest Indian pharma company in the U.S. market, with a sig- nificantly expanded portfolio of life-sav- ing and enhancing medicines. Sun Pharma and Ranbaxy have similar back- grounds and corporate values, with cus- tomer-oriented cultures and research- driven business models. Ranbaxy fits in well with Sun Pharma's network of com- panies serving the U.S. healthcare sys- tem. Taro markets a broad range of pre- scription and OTC products. It is a lead- ing manufacturer and supplier of topical dermatologicals, with a growing line of both topical products and solid dosage formulations mainly used in cardiology and neurology therapies. DUSA is focused on the development and marketing of dermatology products. DUSA's flagship product, Levulan ® pho- todynamic therapy (PDT), is a technology platform used in con- junction with its proprietary light source, the BLU-U ® Blue Light Photodynamic Therapy Illuminator, for the treatment of minimally to moderately thick actinic keratosis of the face or scalp. Pharmalucence is a manufacturer of non-cytotoxic human injectable pharma- ceuticals, in either liquid or lyophilized form. It also specializes in radio pharma- ceutical products. Pharmalucence's 70,000 square foot manufacturing facili- ty is the region's first unit to utilize fully automated and isolated aseptic technolo- gy in support of a wide array of needs, from small clinical fills up to full com- mercial scale production for markets worldwide. Ohm Laboratories is a manufacturer of prescription and OTC drugs in solid dosage forms. Ohm is also approved to manufacture controlled substances by the U.S. Drug Enforcement Agency (DEA). Its state-of-the-art laboratory, manufacturing and warehousing facili- ties are capable of handling high-volume products and large batch sizes, while its supply chain efficiency ensures seam- less transportation to customer locations. Ohm is a frontrunner in bringing unique product deliveries and complex combi- nations to the market. Sun Pharma has built a strong repu- tation as a company that is market driven, focused on customer service and capable of offering a wide range of affordable pharmaceutical products. It continues to expand its product portfolio in the U.S. market to the benefit of patients, pre- scribers and other stakeholders in the healthcare system. It provides high-quality, affordable medicines trusted by healthcare profes- sionals and patients in more than 150 countries of the world. Its presence in 65 key markets around the world is sup- ported by 45 manufacturing facilities across five continents. It has a multi- cultural workforce, comprising more than 30,000 employees of more than 50 nationalities. Visit Sun Pharma at booth #1409. For more information, call 914.345.9001 or go to www.sunpharma.com. THE FUTURE OF PHARMACY AUTOMATION HAS ARRIVED Cornerstone Automation Systems (CASI) is proud to announce a significant advancement in pharmacy automation technology: The Next Generation Pharmacy Automation (NGPA) product line. Already being used by the second largest pharmacy chain in the United Kingdom and by the Department of Veterans Affairs Consolidated Mail Outpatient Pharmacies (CMOPs) in the United States, this pharmacy automation equipment is the first of its kind. CASI designs, manufactures, installs and services pharmacy automation solu- tions to retail store, mail order, long-term care and correctional pharmacies. CASI addresses all production functions including bulk drug ordering and receiv- ing, pre-packaging, on-demand packag- ing, pill canister replenishment, dispens- ing, picking, labeling, sorting, documen- tation printing, bagging, boxing, weigh- ing, shipping and more. The NGPA advances state-of-the-art technology and does for prescription assembly what the robotic car production line did for automobile assembly. The modular platform, which handles all aspects of pharmacy production, is posi- tioned to revolutionize the pharmacy industry. It is the foundation of a dis- pensing model for which the U.K. gov- ernment suggests could potentially cover up to two-thirds of England's dispensing volume. It is also the com- mon platform for which the U.S. government envisions to dispense 100 percent of all U.S. Veteran mail order refill prescriptions. The NGPA product line handles bottles, vials, single-dose cards, multi- dose cards and unit of use (UOU) items. It can pre-pack pills or package pills on demand. Additionally, through advanced technology, packaged prod- uct can be automatically patient labeled without the need for pharmacist verifi- cation. If full or sample pharmacist ver- ification is still desired, prescription validation, label checking and canister fill verification can all be virtually inspected by pharmacists at remote workstations. Additionally, CASI Technology has 100 percent pill count accuracy to avoid oral solid dispensing shortages and overages. CASI also offers total functionality pharmacy software, called SolidSuiteRx, which inter- faces with any Pharmacy Information System, logistics provider, shipping company or other pharmacy control software to seamlessly tie in the product line. SolidSuiteRx directs, con- trols and tracks every operation within the pharmacy production arena, from forecasting bulk demand to verifying delivered patient prescriptions. With the most advanced technology on the market, Cornerstone Automation Systems is slat- ed to revolutionize the pharmacy automation market with its new NGPA product line. Visit Cornerstone Automation Systems at booth #2925. SAY "HI" TO HELLO An interview with Craig Dubitsky, Chief Executive Officer and Founder, hello. CDD: This is a crowded field. How does hello differentiate itself from larger com- petitors? CD: The category has been dominated by a small number of very large brands, but we know that people are looking for alternatives that are more contemporary, more relevant and more authentic. We aren't going to outspend our competition, so we focus on being more unique, more creative and more approachable. Every interaction someone has with hello is authentic, fun, friendly and memorable. We set out to make products that are effective, delicious and beautiful, and as natural as we can make them. We don't use artificial sweeteners, dyes, microbeads, preservatives or triclosan, but we do use high-quality ingredients like xylitol from non-GMO corn and sus- tainably harvested stevia. What's more, all hello products are packaged in BPA- free tubes and made in the U.S.A. They're gluten-free, vegan and aren't tested on animals – and we have the cer- tifications and recognition from groups like PETA and Leaping Bunny to prove it. CDD: What trends are driving the oral care category? CD: It's no secret there's been a surge of consumer interest beyond basic cavity protection. Whitening is becoming cost of entry, especially for younger people. We are also seeing heightened focus on sensitivity. Of course, people today are much more attuned to where their prod- ucts come from and what they're made of. People are looking for more natural ingredients and great design. The oral care category isn't fully delivering on those dimensions, which we see as a huge opportunity for a nimble and authentic brand like hello. CDD: What are the most significant innovations affecting the oral care category right now? CD: It's about giving people both what they need but also what they desire – functional and cosmetic benefits, natural and sustainable ingredients they can feel good about giving to their family, and also something that looks great. But it's not just about product innovation. People want to feel an emotional con- nection to the brands they buy and believe in the people that stand behind those brands. hello is a tight-knit group of passionate professionals and we're thrilled to bring some fun and friendly to the category. CDD: What's hello working on present- ly? CD: We respect a brusher's right to choose, and with that in mind, we recently launched SLS-free and fluoride-free adult and kids paste. We've added aloe vera, erythritol and xylitol to both pastes to help clean and whiten. Our adult version fea- tures a natural sweet mint flavor, and our kids' version has a natural water- melon flavor that's safe for toddlers who often haven't perfected their ability to spit just yet. We're also excited to have launched our new extra whitening paste with no peroxide. It uses a very gentle silica and calcium carbonate to safely and gently remove stains. Like all of our pastes, it tastes amazing. We're actively working on new products, so stay tuned. It's an exciting time at hello! For more information, contact Kim Sines by emailing kim@hello-products.com or calling 201.310.3354.